RT-002 (Respana Therapeutics)

N/A

Report date: 2024/12/16 17:55:29

Base Information

Drug NameRT-002 (Respana Therapeutics)
Drug Alias NameRT-002
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionUnconventional myosin-XVIIIa inhibitors
TargetsUnconventional myosin-XVIIIa
Therapy Area/IndicationsRespiratory Tract Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRespana Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesRespana Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsRespiratory Tract Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A